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Abstract
Background: Camptocormia is defined as forward flexion of the spine that manifests during walking and standing and disappears in recumbent position.
The various etiologies include idiopathic Parkinson’s disease, multiple system atrophy, myopathies, degenerative joint disease, and drugs.
Case Report: A 67-year-old diabetic female presented with bradykinesia and camptocormia that started 1 year prior to presentation. Evaluation revealed
levosulpiride, a dopamine receptor blocker commonly used for dyspepsia, to be the culprit.
Discussion: It is well known that dopamine receptor blockers cause parkinsonism and tardive syndromes. We report a rare and unusual presentation of
camptocormia attributed to this commonly used gastrointestinal drug in the Asian population.
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Introduction
Camptocormia is defined as forward flexion of the spine (.45 )˚ that
manifests during walking and standing and disappears in recumbent
position.1 It has both neurological and musculoskeletal causes. Various
neurological etiologies include idiopathic Parkinson’s disease (PD),
multiple system atrophy, genetic forms of PD, dystonias, myopathies,
and drugs.2 We report a patient who presented with camptocormia
and evaluation disclosed an unusual cause.
Case report
A 67-year-old female presented with change in speech, slowness while
walking, and forward bending of the spine that had started 1 year prior
to presentation. Examination revealed slow hypophonic speech, bilateral
bradykinesia, and rigidity. Gait was slow and short stepped, with gait
initiation difficulty and the presence of camptocormia (Video 1). She
was a known diabetic for 3 years and had a history of coronary artery
disease with an ejection fraction of 45–50%. Her renal functions were
deranged (creatinine 1.9 mg/dL) suggestive of diabetic nephropathy.
There were no red flags in the form of autonomic dysfunction,
pyramidal or cerebellar signs, or cognitive problems to suggest atypical
parkinsonism. She was evaluated to determine the cause of her sym-
metrical parkinsonism. Magnetic resonance imaging of the brain was
normal. 18 F FLUORODOPA (FDOPA) positron emission tomo-
graphy showed bilateral symmetrical uptake of dopamine in the
striatum, thus ruling out a degenerative cause for parkinsonism (Figure
1A,B). Other relevant investigations such as the thyroid profile and
liver function tests were normal. On review of her medical records, it
was found that patient had been taking levosulpiride 75 mg/day for
the last 18 months for her dyspeptic symptoms. There was a
significant improvement in bradykinesia within 10 days of stopping
levosulpiride and starting levodopa/carbidopa (125 mg three times
daily). However, the improvement in camptocormia was modest and
began 2 months after the introduction of levodopa.
At 6 months, there was significant improvement in her symptoms,
and the patient is currently on regular doses of levodopa/carbidopa
(Video 1). She is able to intermittently keep her posture erect with the
reappearance of camptocormia.
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Discussion
Camptocormia is defined as abnormal and severe flexion (.45 )˚ of
the thoracolumbar spine that manifests during walking and standing
and disappears in recumbent position.1 It can occur in sporadic PD,
post-encephalitic and parkin-related PD as well as in multiple system
atrophy.2 The pathogenesis of camptocormia in PD is not fully under-
stood. It may represent a PD-related abnormal posture or be attributed
either to truncal dystonia or to a severe form of rigidity.3 It usually
responds poorly to levodopa but may be alleviated to some extent with
botulinum toxin therapy and deep brain stimulation.4,5 It can also
occur as a tardive syndrome after exposure to dopamine receptor blockers
such as levosulpiride.6 Focal myopathy involving the paravertebral
muscles is another postulate reported in the literature.7
Levosulpiride, a commonly used prokinetic in Asian countries, is a
substituted benzamide that inhibits D2 receptors in the central nervous
system and gastrointestinal tract. It is well known to cause parkin-
sonism, tremor, and tardive dyskinesia.6,8
Neuronal damage in the striatum via oxidative stress and gluta-
matergic transmission on prolonged exposure to neuroleptics underlies
the pathophysiology of tardive syndromes.9 Another school of thought
is that hypersensitivity or upregulation of D2 receptors lead to mal-
adaptive plasticity in the synapses and the cortico-striatal transmission,
which leads to abnormal involuntary movements.10 There is also
evidence of pharmacogenomics in the pathophysiology of tardive
syndromes. Various polymorphisms in the genes encoding D2 and D3
receptors and 5-HT2A receptors, as well as in the CYP2D6 gene, are
known to influence the development of tardive syndromes.11,12
It is well known that drug-induced parkinsonism almost always
resolves when the causative agent is stopped.13 Tardive dystonias, on
the other hand, are usually persistent, and spontaneous remissions are
uncommon. Kiriakakis et al.14 in their study of 107 patients of tardive
dystonia found that only 14% of patients showed remission after a mean
duration of 8.5 years. The abnormal flexion of the spine in our patient
took more than 2 months to resolve, and is therefore more likely to be
Video 1. Segment 1. The presence of camptocormia and short step gait.
Segment 2. The near complete resolution of camptocormia with improvement
in slowness.
Figure 1. Structural and Functional Imaging of the Brain. (A) T2 weighted magnetic resonance imaging brain shows normal appearing bilateral basal
ganglia. (B) 18 F FLUORODOPA (FDOPA) positron emission tomography revealed adequate tracer uptake in bilateral striatum.
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due to tardive dystonia. Bradykinesia that resolves in less than 2 weeks
suggests it to be the result of drug-induced parkinsonism.
Presentation with camptocormia was slightly unusual in our patient.
In our patient, the strong temporal relationship of occurrence of
camptocormia with levosulpiride intake in the presence of normal
structural and functional imaging indicates a causative association. To
the best of our knowledge, levosulpiride-induced camptocormia has
not been previously reported in the literature.
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